Brucellosis pathophysiology

Brucellosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Brucellosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Principles of diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
CT Scan
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Brucellosis pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Brucellosis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Brucellosis pathophysiology
CDC on Brucellosis pathophysiology
Brucellosis pathophysiology in the news
Blogs on Brucellosis pathophysiology
Directions to Hospitals Treating Brucellosis
Risk calculators and risk factors for Brucellosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza Lukac

Pathophysiology

Transmission

• Brucella spp. are primarily passed among animals, and they cause disease in many different vertebrates.
• Various Brucella species affect sheep, goats, cattle, deer, elk, pigs, dogs, american bishop and several other animals.
• Humans are generally infected in one of three ways:
  • Eating undercooked meat or consuming unpasteurized/raw dairy products
    • The most common way to be infected is by eating or drinking unpasteurized/raw dairy products.
    • When sheep, goats, cows, or camels are infected, their milk becomes contaminated with the bacteria.
    • If the milk from infected animals is not pasteurized, the infection will be transmitted to people who consume the milk and/or cheese products.
  • Breathing in the bacteria that cause brucellosis (inhalation)
    • This risk is generally greater for people in laboratories that work with the bacteria.
    • Slaughterhouse and meat-packing employees have also been known to be exposed to the bacteria and ultimately become infected.
  • Bacteria entering the body through skin wounds or mucous membranes through contact with infected animals.
    • This poses a problem for workers who have close contact with animals or animal excretions (newborn animals, fetuses, and excretions that may result from birth).
    • Such workers may include:
      • Slaughterhouse workers
      • Meat-packing plant employees
      • Veterinarians
• Person-to-person spread of brucellosis is extremely rare.
• Infected mothers who are breast-feeding may transmit the infection to their infants.
• Sexual transmission has been rarely reported.
• While uncommon, transmission may also occur via tissue transplantation or blood transfusions.

Pathogenesis

• Virulent Brucella organisms can infect both nonphagocytic and phagocytic cells.
• When Brucella enters the body white blood cells (WBC), particularly neutrophils and macrophages phagocyte the pathogen.
  • WBC transports the pathogen via hematologic and lymphatic routes to different organs, specially to the reticuloendothelial system (RES).
  • Brucella multiplies themselves within the vacuoles of the phagocytes without being destructed.
• Different Brucella species are classified as smooth and rough lipopolysaccharide phenotypes.
  • Smooth lipopolysaccharides (S-LPS):
    • B. abortus, B. melitensis, B. suis and B. neotoma
    • S-LPS are more virulent than R-LPS
    • S-LPS survive much more effectively than nonsmooth ones
  • Rough lipopolysaccharides (R-LPS):
    • B. ovis and B. canis
• In polymorphonuclear or mononuclear phagocytic cells, Brucella spp. uses a number of mechanisms for avoiding or suppressing bactericidal responses:
  • Lipopolysaccharide and outer membrane proteins probably play a substantial role in intracellular survival.
    • This may be due to the mannose and integrins receptors.
  • Brucella stays within the cells because it inhibits cellular mechanisms of programmed cell death (apoptosis).
  • The survival of Brucella within the cells has been associated with:
    • Synthesis of antioxidant enzymes
    • Production of guanosine 5 monophosphate (GMP)
      • GMP inhibits: phagolysosome fusion, degranulation and activation of the myelo-peroxidase-halide system, and production of tumor necrosis factor.
    • Synthesis of proteins of molecular weight 17, 24, 28, 60, and 62 kDa.
      • The 24 kDa protein is acid-induced, and its production correlates with bacterial survival under acidic conditions (<pH4).
      • The 17 and 28 kDa proteins are apparently specifically induced by macrophages and correlated with intracellular survival.
• The elimination of virulent Brucella depends on activated macrophages and hence requires development of Th1 type cell-mediated responses to protein antigens.
• High iron concentrations promote the killing of Brucella, probably by favoring production of hydroxylamine and hydroxyl radical.
• The mechanisms of pathogenesis of Brucella infection in its natural host species and in humans are still not completely understood, and further studies are needed.

Microscopic Pathology

Brucella spp. are poorly staining, small gram-negative coccobacilli (0.5-0.7 x 0.6-1.5 µm), and are seen mostly as single cells and appearing like “fine sand”.

Histopathology of guinea pig liver in experimental Brucella suis infection. Granuloma with necrosis

• Brucella spp. are poorly staining, small gram-negative coccobacilli (0.5-0.7 x 0.6-1.5 µm).
• Brucella spp. are seen mostly as single cells and appearing like “fine sand”.
• On microscopic histopathological analysis of the liver, common findings are:
  • Granulomas with centrilobular necrosis or focal necrosis and parenchyma destruction.